🇺🇸 FDA
Patent

US 9764022

Methods and compositions for inhibiting polyomavirus-associated pathology

granted A61KA61K2039/5258A61K2039/55566

Quick answer

US patent 9764022 (Methods and compositions for inhibiting polyomavirus-associated pathology) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K2039/5258, A61K2039/55566, A61K2039/70, A61K39/12